Of course, there are exceptions to this
With funding from the National Institutes of Health, the study, which included more than 300,000 adults with Type 2 diabetes, produced results that suggest use of glucagon-like peptide-1 receptor agonists, or GLP-1 RAs, and sodium-glucose cotransporter-2 inhibitors, or SGLT2 inhibitors, were associated with a significant reduction in risk of Alzheimers disease and related dementias compared with use of older medications, such as sulfonylureas or DPP4 inhibitors
The discourse drones on, but I still have a disease to manage and choices to make
Researchers have found that weekly doses of methylcobalamin offer neurological therapeutic value
Read more Do GLP-1 drugs cause muscle loss
My ankle would swell after simple workouts, feel stiff during hikes, and the pain often lingered for days